ImpediMed Limited
IPDQF
$0.0445
$0.004812.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.57% | 28.51% | -3.39% | -5.78% | -15.47% |
| Total Other Revenue | -- | -- | -71.97% | -67.70% | 72.26% |
| Total Revenue | 25.57% | 28.51% | -4.02% | -6.39% | -16.17% |
| Cost of Revenue | 13.45% | 16.09% | -8.47% | -10.71% | -22.80% |
| Gross Profit | 27.42% | 30.40% | -3.36% | -5.75% | -15.07% |
| SG&A Expenses | -6.37% | -4.18% | -1.06% | -3.51% | 9.29% |
| Depreciation & Amortization | 89.59% | 94.02% | -17.88% | -19.89% | -0.47% |
| Other Operating Expenses | 65.38% | 69.22% | 21.39% | 18.39% | -79.29% |
| Total Operating Expenses | 2.47% | 4.86% | 0.58% | -1.91% | -4.84% |
| Operating Income | 6.47% | 4.28% | -3.03% | -0.49% | -0.41% |
| Income Before Tax | -14.81% | -17.49% | -2.32% | 0.20% | 10.95% |
| Income Tax Expenses | -44.62% | -43.08% | 59.26% | 59.26% | -14.47% |
| Earnings from Continuing Operations | -14.68% | -17.36% | -2.37% | 0.16% | 10.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.68% | -17.36% | -2.37% | 0.16% | 10.96% |
| EBIT | 6.47% | 4.28% | -3.03% | -0.49% | -0.41% |
| EBITDA | 16.43% | 14.48% | -2.99% | -0.61% | -0.50% |
| EPS Basic | -- | -- | 11.11% | 11.11% | 100.00% |
| Normalized Basic EPS | -- | -- | 9.09% | 9.09% | 100.00% |
| EPS Diluted | -- | -- | 11.11% | 11.11% | 100.00% |
| Normalized Diluted EPS | -- | -- | 9.09% | 9.09% | 100.00% |
| Average Basic Shares Outstanding | 0.15% | 0.15% | 12.45% | 12.45% | 113,307.04% |
| Average Diluted Shares Outstanding | 0.15% | 0.15% | 12.45% | 12.45% | 113,307.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
